litlas
ログインアカウント作成

Andrew M. Scott

1969–2026 年に発表

別表記
Andrew M Scott
231
論文数
25,938
被引用数
93
h 指数
218
i10 指数

被引用数

Andrew M. Scott の年別被引用数1983 年: 被引用 2 件1990 年: 被引用 3 件1991 年: 被引用 3 件1992 年: 被引用 4 件1993 年: 被引用 3 件1994 年: 被引用 15 件1995 年: 被引用 27 件1996 年: 被引用 12 件1997 年: 被引用 35 件1998 年: 被引用 36 件1999 年: 被引用 59 件2000 年: 被引用 57 件2001 年: 被引用 70 件2002 年: 被引用 57 件2003 年: 被引用 98 件2004 年: 被引用 99 件2005 年: 被引用 151 件2006 年: 被引用 125 件2007 年: 被引用 184 件2008 年: 被引用 148 件2009 年: 被引用 158 件2010 年: 被引用 122 件2011 年: 被引用 133 件2012 年: 被引用 166 件2013 年: 被引用 186 件2014 年: 被引用 152 件2015 年: 被引用 215 件2016 年: 被引用 179 件2017 年: 被引用 247 件2018 年: 被引用 305 件2019 年: 被引用 756 件2020 年: 被引用 859 件2021 年: 被引用 995 件2022 年: 被引用 823 件2023 年: 被引用 748 件2024 年: 被引用 1,319 件2025 年: 被引用 791 件2026 年: 被引用 24 件1984〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,980 件、この内訳の 23.5%中国: 引用元論文 1,483 件、この内訳の 11.7%ドイツ: 引用元論文 806 件、この内訳の 6.3%オーストラリア: 引用元論文 740 件、この内訳の 5.8%イギリス: 引用元論文 673 件、この内訳の 5.3%イタリア: 引用元論文 487 件、この内訳の 3.8%オランダ: 引用元論文 427 件、この内訳の 3.4%フランス: 引用元論文 387 件、この内訳の 3%カナダ: 引用元論文 363 件、この内訳の 2.9%スイス: 引用元論文 309 件、この内訳の 2.4%日本: 引用元論文 298 件、この内訳の 2.3%スペイン: 引用元論文 275 件、この内訳の 2.2%
0%23.5%その他 27.4%

機関

分野

  • Medicine58.8%
  • Biochemistry, Genetics and Molecular Biology23.6%
  • Immunology and Microbiology6%
  • Materials Science3.4%
  • Engineering2.3%
  • Neuroscience1.9%
  • その他4%

トピック

  • Monoclonal and Polyclonal Antibodies Research3.8%
  • Extracellular vesicles in disease3.8%
  • CAR-T cell therapy research3.7%
  • Radiopharmaceutical Chemistry and Applications3.6%
  • Prostate Cancer Treatment and Research2.7%
  • Immunotherapy and Immune Responses2.5%
  • その他79.9%

共著者

全論文

検索で開く
  1. [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

    著者: Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, Anthony M. Joshua, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Siobhan Ng, Roslyn J. Francis, Craig Gedye, Natalie Rutherford, Andrew Weickhardt, Andrew M. Scott, Sze-Ting Lee, Edmond M. Kwan, Arun Azad, Shakher Ramdave, Andrew Redfern, W A Macdonald, Alex Guminski, Edward Hsiao, Wei Chua, Peter Lin, Alison Y. Zhang, Margaret McJannett, Martin R. Stockler, John Violet, Scott Williams, Andrew Martin, Ian D. Davis, Arun Azad, Wei Chua, Ian D. Davis, Nattakorn Dhiantravan, Louise Emmett, Kate Ford, Michael S. Hofman, Roslyn J. Francis, Craig Gedye, Jeffrey C. Goh, Alex Guminski, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Siobhan Ng, David A. Pattison, Shakher Ramdave, Nisha Rana, Andrew Redfern, Natalie Rutherford, Shahneen Sandhu, Andrew M. Scott, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, John Violet, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang - The Lancet 2021 被引用: 1,082

  2. Radiotheranostics in oncology: current challenges and emerging opportunities

    著者: Lisa Bodei, Ken Herrmann, Heiko Schöder, Andrew M. Scott, Jason S. Lewis - Nature Reviews Clinical Oncology 2022 被引用: 373

  3. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes

    著者: Bow J. Tauro, David W. Greening, Rommel A. Mathias, Hong Ji, Suresh Mathivanan, Andrew M. Scott, Richard J. Simpson - Methods 2012 被引用: 1,154

  4. Antibody therapy of cancer

    著者: Andrew M. Scott, Jedd D. Wolchok, Lloyd J. Old - Nature reviews. Cancer 2012 被引用: 2,149

  5. FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy

    著者: Jack D. Chan, C. Scheffler, Isabelle Munoz, Kevin Sek, Joel N. Lee, Yukuan Huang, Kah Min Yap, Nicole Y. L. Saw, Jasmine Li, Amanda X. Y. Chen, Cheok Weng Chan, Emily B. Derrick, Kirsten L. Todd, Junming Tong, Phoebe Dunbar, Jiawen Li, Thang X. Hoang, Maria N. de Menezes, Emma V. Petley, Joelle S. Kim, Dat Quoc Nguyen, P. Leung, Joan So, Christian Deo T. Deguit, Joe Jiang Zhu, Imran G. House, Lev M. Kats, Andrew M. Scott, Benjamin Solomon, Simon J. Harrison, Jane Oliaro, Ian A. Parish, Kylie M. Quinn, Paul J. Neeson, Clare Y. Slaney, Junyun Lai, Paul A. Beavis, Phillip K. Darcy - Nature 2024 被引用: 214

  6. Antibody–Drug Conjugates for Cancer Therapy

    著者: Umbreen Hafeez, Sagun Parakh, Hui Gan, Andrew M. Scott - Molecules 2020 被引用: 383

  7. PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial

    著者: James P Buteau, Andrew Martin, Louise Emmett, Amir Iravani, Shahneen Sandhu, Anthony M. Joshua, Roslyn J. Francis, Alison Y. Zhang, Andrew M. Scott, Sze-Ting Lee, Arun Azad, Margaret McJannett, Martin R. Stockler, Scott Williams, Ian D. Davis, Michael S. Hofman, Tim Akhurst, Ramin Alipour, Arun Azad, Patricia Banks, Alexis Beaulieu, James P Buteau, Wei Chua, Ian D. Davis, Nattakorn Dhiantravan, Louise Emmett, Kate Ford, Michael S. Hofman, Roslyn J. Francis, Craig Gedye, Jeffrey C. Goh, Alex Guminski, Anis Hamid, Mohammad B. Haskali, Rodney J. Hicks, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Grace Kong, Edmond M. Kwan, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Jeremy Lewin, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Kate Moodie, Declan G. Murphy, Siobhan Ng, David A. Pattison, Izabella Pokorski, Shakher Ramdave, Aravind S. Ravi Kumar, Andrew Redfern, Natalie Rutherford, Javad Saghebi, Shahneen Sandhu, Andrew M. Scott, Lavinia Spain, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, Sue Ping Thang, Ben Tran, Roslyn E. Wallace, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang, Sonia Yip, Alison Y. Zhang - The Lancet Oncology 2022 被引用: 266

  8. Medical imaging and nuclear medicine: a Lancet Oncology Commission

    著者: Hedvig Hricak, May Abdel–Wahab, Rifat Atun, Miriam Mikhail-Lette, Diana Páez, James A. Brink, Lluís Donoso-Bach, Guy Frija, Monika Hierath, Ola Holmberg, Pek‐Lan Khong, Jason S. Lewis, Geraldine McGinty, Wim J.G. Oyen, Lawrence N. Shulman, Zachary J. Ward, Andrew M. Scott - The Lancet Oncology 2021 被引用: 341

  9. Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

    著者: Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, James P Buteau, Anthony M. Joshua, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Siobhan Ng, Roslyn J. Francis, Craig Gedye, Natalie Rutherford, Andrew Weickhardt, Andrew M. Scott, Sze-Ting Lee, Edmond M. Kwan, Arun Azad, Shakher Ramdave, Andrew Redfern, W A Macdonald, Alex Guminski, Edward Hsiao, Wei Chua, Peter Lin, Alison Yan Zhang, Martin R. Stockler, Scott Williams, Andrew Martin, Ian D. Davis, Tim Akhurst, Ramin Alipour, Dale L. Bailey, Patricia Banks, Alexis Beaulieu, Louise Campbell, Megan Crumbaker, Nattakorn Dhiantravan, Anis Hamid, Mohammad B. Haskali, Terry Hung, Grace Kong, Nick Lawrence, Jeremy Lewin, Michael McCarthy, Kate Moodie, Declan G. Murphy, Andrew Nguyen, David Pook, Aravind Ravi Kumar, Paul Roach, Peter Roselt, Javad Saghebi, Geoffrey Schembri, Lavinia Spain, Shalini Subramaniam, Sue Ping Thang, Paul Thomas, Ben Tran, Roslyn E. Wallace, Sonia Yip - The Lancet Oncology 2023 被引用: 199

  10. Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis

    著者: Zeyad D. Nassar, Chui Y. Mah, Jonas Dehairs, Ingrid J.G. Burvenich, Swati Irani, Margaret M. Centenera, Madison Helm, Raj K. Shrestha, Max Moldovan, Anthony S. Don, Jeff Holst, Andrew M. Scott, Lisa G. Horvath, David J. Lynn, Luke A. Selth, Andrew J. Hoy, Johannes V. Swinnen, Lisa M. Butler - eLife 2020 被引用: 201

  11. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

    著者: Andrew M. Scott, G. Wiseman, Sydney Welt, Alex A. Adjei, Fook-Thean Lee, Wendie Hopkins, C R Divgi, Lorelei H Hanson, Paul Mitchell, Denise N. Gansen, Steven M. Larson, James N. Ingle, Eric W. Hoffman, P. Tanswell, Gerd Ritter, Leonard Cohen, Peter Bette, Lisa Arvay, A. Amelsberg, Dan Vlock, Wolfgang J. Rettig, Lloyd J. Old - 2003 被引用: 442

  12. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group

    著者: Nathalie L. Albert, Norbert Galldiks, Benjamin M. Ellingson, Martin J. van den Bent, Susan M. Chang, Francesco Cicone, John de Groot, Eng‐Siew Koh, Ian Law, Émilie Le Rhun, Maximilian J. Mair, Giuseppe Minniti, Roberta Rudà, Andrew M. Scott, Susan Short, Marion Smits, Bogdana Suchorska, Nelleke Tolboom, Tatjana Traub‐Weidinger, J. C. Tonn, Antoine Verger, Michael Weller, Patrick Y. Wen, Matthias Preusser - The Lancet Oncology 2024 被引用: 146

  13. T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models

    著者: Déborah Meyran, Joe Jiang Zhu, Jeanne Butler, Daniela Tantalo, Sean Macdonald, Thu Ngoc Nguyen, Minyu Wang, Niko Thio, Criselle D’Souza, Vicky Mengfei Qin, Clare Y. Slaney, Aaron J Harrison, Kevin Sek, Pasquale Petrone, Kevin Thia, Lauren Giuffrida, Andrew M. Scott, Rachael Terry, Ben Tran, Jayesh Desai, H. Miles Prince, Simon J. Harrison, Paul A. Beavis, Michael H. Kershaw, Benjamin Solomon, Paul G. Ekert, Joseph A. Trapani, Phillip K. Darcy, Paul J. Neeson - Science Translational Medicine 2023 被引用: 97

  14. Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia

    著者: David S. Ritchie, Paul J. Neeson, Amit Khot, Stefan Peinert, Tsin Yee Tai, Kellie M. Tainton, Karen Chen, Mandy Shin, Dominic Wall, Dirk Hönemann, Peter Gambell, David Westerman, Javier Haurat, Jennifer A. Westwood, Andrew M. Scott, L. Ya. Kravets, Michael Dickinson, Joseph A. Trapani, Mark J. Smyth, Phillip K. Darcy, Michael H. Kershaw, H. Miles Prince - Molecular Therapy 2013 被引用: 433

  15. Radiotherapy and theranostics: a Lancet Oncology Commission

    著者: May Abdel–Wahab, Francesco Giammarile, M. Carrara, Diana Páez, Hedvig Hricak, Nayyereh Ayati, Jing Jing Li, Malina Mueller, Ajay Aggarwal, Akram Al‐Ibraheem, Sondos A. Al-Khatib, Rifat Atun, Abubakar Bello, Daniel Berger, Roberto C. Delgado Bolton, John M. Buatti, Graeme Burt, Olivera Ciraj‐Bjelac, Lisbeth Cordero-Mendez, Manjit Dosanjh, Thomas Eichler, Elena Fidarova, Soehartati Gondhowiardjo, Mary Gospodarowicz, Surbhi Grover, Varsha Hande, Ekaterina Harsdorf-Enderndorf, Ken Herrmann, Michael S. Hofman, Ola Holmberg, David A. Jaffray, Peter Knoll, Jolanta Kunikowska, Jason S. Lewis, Yolande Lievens, Miriam Mikhail-Lette, Dennis A. Ostwald, Jatinder Palta, Platon Peristeris, Arthur Accioly Rosa, Soha Ahmed Salem, Marcos Augusto dos Santos, Mike Sathekge, Shyam Kishore Shrivastava, Egor Titovich, Jean-Luc Urbain, Verna Vanderpuye, Richard L. Wahl, Jennifer S. Yu, Mohamed S. Zaghloul, Hongcheng Zhu, Andrew M. Scott - The Lancet Oncology 2024 被引用: 120

  16. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.

    著者: S Welt, C R Divgi, Andrew M. Scott, Pilar Garin‐Chesa, Ronald D. Finn, Martin C. Graham, E A Carswell, Alfred Cohen, Steven M. Larson, Lloyd J. Old - Journal of Clinical Oncology 1994 被引用: 262

  17. Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma

    著者: I. Nicholson, Kelly A. Lenton, Debbie J. Little, Tina Decorso, Fook Thean Lee, Andrew M. Scott, Heddy Zola, A Hohmann - Molecular Immunology 1997 被引用: 232

  18. Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases

    著者: Umbreen Hafeez, Hui Gan, Andrew M. Scott - Current Opinion in Pharmacology 2018 被引用: 178

  19. Radiolabeled Antibodies for Cancer Imaging and Therapy

    著者: Sagun Parakh, Sze Ting Lee, Hui Gan, Andrew M. Scott - Cancers 2022 被引用: 109

  20. Bridging Bio–Nano Science and Cancer Nanomedicine

    著者: Mattias Björnmalm, Kristofer J. Thurecht, Michael Michael, Andrew M. Scott, Frank Caruso - ACS Nano 2017 被引用: 378

  21. [89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial

    著者: Brian Shuch, Allan J. Pantuck, Jean‐Christophe Bernhard, Michael A. Morris, Viraj Master, Andrew M. Scott, Charles van Praet, Clément Bailly, Bülent Önal, Tamer Aksoy, Robin Merkx, David M Schuster, Sze Ting Lee, Neeta Pandit‐Taskar, Alice C. Fan, Phillip Allman, Karl P. Schmidt, Libuse Tauchmanovà, Michael Wheatcroft, Christian Behrenbruch, Colin Hayward, Peter Mulders - The Lancet Oncology 2024 被引用: 127

  22. Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects

    著者: Zhipeng Cao, Sadia Quazi, Sakshi Arora, Laura D. Osellame, Ingrid J.G. Burvenich, Peter W. Janes, Andrew M. Scott - Journal of Biomedical Science 2025 被引用: 68

  23. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0

    著者: Egesta Lopci, Rodney J. Hicks, Antonia Dimitrakopoulou‐Strauss, Laurent Dercle, Amir Iravani, Romain‐David Seban, Christos Sachpekidis, Olivier Humbert, Olivier Gheysens, Andor W.J.M. Glaudemans, Wolfgang Weber, Richard L. Wahl, Andrew M. Scott, Neeta Pandit‐Taskar, Nicolas Aide - European Journal of Nuclear Medicine and Molecular Imaging 2022 被引用: 105

  24. ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

    著者: Margaret M. Centenera, Julia S. Scott, Jelle Machiels, Zeyad D. Nassar, Deanna C. Miller, Irene Zinonos, Jonas Dehairs, Ingrid J.G. Burvenich, Giorgia Zadra, Paolo Chetta, Clyde Bango, Emma Evergren, Natalie K. Ryan, Joanna L. Gillis, Chui Y. Mah, Terence Tieu, Adrienne R. Hanson, Ryan Carelli, Katarzyna Bloch, Vasilios Panagopoulos, Etienne Waelkens, Rita Derua, Elizabeth D. Williams, Andreas Evdokiou, Anna Cifuentes‐Rius, Nicolas H. Voelcker, Ian G. Mills, Wayne D. Tilley, Andrew M. Scott, Massimo Loda, Luke A. Selth, Johannes V. Swinnen, Lisa M. Butler - Cancer Research 2021 被引用: 96